Cargando…

Uveitis manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study

BACKGROUND: The knowledge about risk factors for the onset of uveitis manifestations in patients with inflammatory bowel disease (IBD) is still limited. Here, we aimed to provide an overview of the clinical factors associated with the onset of uveitis in the Swiss IBD Cohort Study (SIBDCS). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biedermann, Luc, Renz, Laura, Fournier, Nicolas, Rossel, Jean-Benoît, Butter, Matthias, Bluemel, Sena, Vavricka, Stephan R., Rogler, Gerhard, Scharl, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693019/ https://www.ncbi.nlm.nih.gov/pubmed/31447932 http://dx.doi.org/10.1177/1756284819865142

Ejemplares similares

The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort
por: Hiller, Aimee, et al.
Publicado: (2019)

Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort study
por: Grob, Lorenz, et al.
Publicado: (2020)

Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study
por: Roth, Nina, et al.
Publicado: (2019)

Genetic risk factors predict disease progression in Crohn’s disease patients of the Swiss inflammatory bowel disease cohort
por: Ditrich, Felicitas, et al.
Publicado: (2020)

The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients
por: Roth, René, et al.
Publicado: (2021)

Widely differing screening and treatment practice for osteoporosis in patients with inflammatory bowel diseases in the Swiss IBD cohort study
por: Schüle, Solvey, et al.
Publicado: (2017)

Extraintestinal Manifestations of Inflammatory Bowel Disease
por: Vavricka, Stephan R., et al.
Publicado: (2015)

Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study
por: Bon, Lorenz, et al.
Publicado: (2019)

Genotype-Phenotype Associations of the CD-Associated Single Nucleotide Polymorphism within the Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 22 in Patients of the Swiss IBD Cohort
por: Spalinger, Marianne R., et al.
Publicado: (2016)

Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases
por: Fagagnini, Stefania, et al.
Publicado: (2017)

Genotype–phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients
por: Yoganathan, Priyatharsan, et al.
Publicado: (2021)

The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients
por: Yilmaz, Bahtiyar, et al.
Publicado: (2018)

The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease
por: Vögelin, Marius, et al.
Publicado: (2016)

Patients’ perceptions on the impact of coffee consumption in inflammatory bowel disease: friend or foe? – a patient survey
por: Barthel, Christiane, et al.
Publicado: (2015)

Anemia in Inflammatory Bowel Disease: An Under-Estimated Problem?
por: Rogler, Gerhard, et al.
Publicado: (2015)

Prevalence and Risk Factors for Therapy Escalation in Ulcerative Colitis in the Swiss IBD Cohort Study
por: Safroneeva, Ekaterina, et al.
Publicado: (2015)

Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account
por: Zeitz, Jonas, et al.
Publicado: (2016)

Lifestyle factors associated with inflammatory bowel disease: data from the Swiss IBD cohort study
por: Lautenschlager, Severin A., et al.
Publicado: (2023)

Concomitant 5-aminosalicylic acid treatment does not affect 6-thioguanine nucleotide levels in patients with inflammatory bowel disease on thiopurines
por: Looser, Rahel, et al.
Publicado: (2023)

Effects of anti-TNF therapy and immunomodulators on anxiety and depressive symptoms in patients with inflammatory bowel disease: a 5-year analysis
por: Siebenhüner, Alexander R., et al.
Publicado: (2021)

Microbial Sensing by the Intestinal Epithelium in the Pathogenesis of Inflammatory Bowel Disease
por: Scharl, Michael, et al.
Publicado: (2010)

Fistulizing Crohn’s Disease
por: Scharl, Michael, et al.
Publicado: (2017)

Effect of closed and permanent stoma on disease course, psychological well-being and working capacity in Swiss IBD cohort study patients
por: Bianchi, Rahel, et al.
Publicado: (2022)

Modulation of the Mucosa-Associated Microbiome Linked to the PTPN2 Risk Gene in Patients with Primary Sclerosing Cholangitis and Ulcerative Colitis
por: Denoth, Luisa, et al.
Publicado: (2021)

Impact of Overweight and Obesity on Disease Outcome in the Pediatric Swiss Inflammatory Bowel Disease Cohort
por: von Graffenried, Thea, et al.
Publicado: (2022)

Protocol for a prospective, controlled, observational study to evaluate the influence of hypoxia on healthy volunteers and patients with inflammatory bowel disease: the Altitude IBD Study
por: Vavricka, Stephan, et al.
Publicado: (2017)

Protein Tyrosine Phosphatase Non-Receptor Type 22 Modulates NOD2-Induced Cytokine Release and Autophagy
por: Spalinger, Marianne R., et al.
Publicado: (2013)

Fc Gamma Receptor CD64 Modulates the Inhibitory Activity of Infliximab
por: Wojtal, Kacper A., et al.
Publicado: (2012)

Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management
por: Ledergerber, Martina, et al.
Publicado: (2021)

Low serum zinc levels predict presence of depression symptoms, but not overall disease outcome, regardless of ATG16L1 genotype in Crohn’s disease patients
por: Greuter, Thomas, et al.
Publicado: (2018)

VAlidation of an 8-item-questionnaire predictive for a positive caLprotectin tEst and Real-life implemenTation in primary care to reduce diagnostic delay in inflammatory bowel disease (ALERT): protocol for a prospective diagnostic study
por: Hasler, Susann, et al.
Publicado: (2015)

Because I’m happy – positive affect and its predictive value for future disease activity in patients with inflammatory bowel diseases: a retrospective cohort study
por: Lang, Brian M., et al.
Publicado: (2023)

Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland
por: Perrig, Kathrin, et al.
Publicado: (2022)

Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease
por: Martinho-Grueber, Maude, et al.
Publicado: (2022)

Smoking Cessation Induces Profound Changes in the Composition of the Intestinal Microbiota in Humans
por: Biedermann, Luc, et al.
Publicado: (2013)

Inflammatory bowel disease in sub-Saharan Africa: a protocol of a prospective registry with a nested case–control study
por: Katsidzira, Leolin, et al.
Publicado: (2020)

Stromal Cells in the Pathogenesis of Inflammatory Bowel Disease
por: Barnhoorn, M C, et al.
Publicado: (2020)

Bilberry-Derived Anthocyanins Modulate Cytokine Expression in the Intestine of Patients with Ulcerative Colitis
por: Roth, Sofia, et al.
Publicado: (2016)

Perianal fistulodesis – A pilot study of a novel minimally invasive surgical and medical approach for closure of perianal fistulae
por: Villiger, Roxanne, et al.
Publicado: (2021)

Impact of Diagnostic Delay on Disease Course in Pediatric- versus Adult-Onset Patients with Ulcerative Colitis: Data from the Swiss IBD Cohort
por: Schoepfer, Alain M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_49vh0eslnjnlnikpt1dstf04t2